Works Minister Alexander Nanta Linggi attributed delays in the Sabah Pan Borneo Highway project to changes in its ...
A new case report documents 127 days of persistent SARS-CoV-2 RNA positivity in a woman with chronic lymphocytic leukaemia, ...
The World Health Organization says a possible case of pneumonic plague in Russia presents a “very low” risk outside the ...
Identifying the thousands of small molecules circulating in human blood has long been one of the most stubborn bottlenecks in ...
Star, three-time All-NBA selection, 2016 NBA Rookie of the Year, and 2026 NBA Champion Karl-Anthony Towns brings his personal ...
About LIBERTY LIBERTY is a Phase 3, randomized, double-blind clinical trial to evaluate the safety, serum virus neutralizing antibody responses, and pharmacokinetics of VYD2311, an mRNA COVID vaccine, ...
Invivyd, Inc. announced positive, clinically meaningful, and statistically significant topline data from the LIBERTY Phase 3, randomized, double-blind, active controlled study evaluating the safety ...
The investigational monoclonal antibody, VYD2311, (Invivyd) met all primary and key secondary endpoints in the phase 3 LIBERTY study. It showed safety and tolerability superior to an mRNA-based ...
As the Lab School teachers prepared to enter the third academic year affected by the COVID-19 pandemic, I asked them to reflect on the challenges and highlights of teaching during the pandemic. March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results